Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Mclellan (Cambridge, United Kingdom), P. George (London, United Kingdom), P. Ford (Antwerp, Belgium), J. De Backer (Antwerp, Belgium), C. Van Holsbeke (Antwerp, Belgium), B. Mignot (Antwerp, Belgium), A. Ruggiero (Cambridge , United Kingdom), M. Thillai (Cambridge , United Kingdom). Late Breaking Abstract - Change in airway volume, measured with functional respiratory imaging (FRI), differentiates between stable and progressive idiopathic pulmonary fibrosis (IPF). 1317

Member's Comments

No comment yet.

Related content which might interest you: Serum surfactant protein D (SP-D) and annual decline of diffusion capacity are prognostic factors for combined pulmonary fibrosis with emphysema (CPFE) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Clinical respiratory physiology in different diseases Year: 2013 Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods Source: International Congress 2015 – IPF: clinical aspects Year: 2015 A six minute walking test (6MWT) derived index (O2-GAP) predicts mortality in IPF Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Novel CT markers of volume loss in idiopathic pulmonary fibrosis (IPF) predict mortality Source: International Congress 2017 – Novel imaging findings characterising various lung diseases and their prognoses Year: 2017 Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions Year: 2013 Comparison of ventilation heterogeneity (VH) measured with multiple breath washout (MBW) imaging to whole lung MBW LCI and FEV1 in asthma and cystic fibrosis (CF) Source: International Congress 2015 – Functional imaging approaches for evaluating alteration of lung, airways and respiratory muscles Year: 2015 Quantitative computed tomography (QCT) measured 5th generation airways, emphysema and airflow obstruction in chronic obstructive pulmonary disease (COPD) from a COPDMAP cohort Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Does adventitious sound reflect the physiology of idiopathic pulmonary fibrosis (IPF)? Source: Eur Respir J 2007; 30: Suppl. 51, 578s Year: 2007 High resolution computed tomography (HRCT) can differentiate rapid from slow progressing Idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 2 Year: 2014 Assessment of the potential utility of alveolar volume (VA) as a surrogate for total lung capacity (TLC) Source: International Congress 2014 – Respiratory function at rest and during exercise Year: 2014 Are there differences in response to pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF) and COPD patients? Source: International Congress 2017 – New insights into pulmonary rehabilitation in patients with chronic lung diseases Year: 2017 Structural brain changes in patients with chronic obstructive pulmonary disease (COPD) Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? Source: International Congress 2017 – IPF: from the bench to the bedside Year: 2017 Sarcopenia in idiopathic pulmonary fibrosis (IPF): Prevalence and response to pulmonary rehabilitation (PR) Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation Year: 2020 Understanding the relationship between percentage emphysema as assessed by volumetric CT and lung function in patients with chronic obstructive pulmonary disease Source: International Congress 2014 – Multidimensional analysis of respiratory problems Year: 2014 Serologically assessed elastin degradation is related to force vital capacity in patients with IPF Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Familial pulmonary fibrosis: Respiratory function progression analysis in different HRCT patterns Source: International Congress 2015 – IPF: clinical aspects II Year: 2015 Outcome differences between idiopathic pulmonary fibrosis (IPF) and other interstitial lung diseases (ILD) - data from the EXCITING registry Source: International Congress 2018 – The world of idiopathic pulmonary fibrosis (IPF): global registries Year: 2018 Late Breaking Abstract: Pulmonary hypertension (PH) in patients with idiopathic pulmonary fibrosis (IPF) in early course of disease – A prospective evaluation with right heart catheterization (RHC) in the ARTEMIS-IPF study Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010